- Next-week expectancy is positive at 57.14% based on similar historical setup states.
- Latest weekly return ranks in the strongest part of its sector group.
SFZN
EBS
Week ended 31 Jul 2026
Weekly Investor Report
Siegfried Holding AG · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
76.55 CHF
8.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -3.3% below the Trend Line and sits at 28.6% of its 52-week range. The latest completed week returned 8.3%, after a 6.6% four-week move. The latest news-sentiment score is 52/100.
Setup score
40
out of 100
Latest Close
76.55 CHF
31 Jul 2026
1W Return
8.3%
latest completed week
4W Return
6.6%
short-term follow-through
12W Return
-6.7%
quarterly tape
Trend Breadth
11.5%
6 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
8.3%
Latest completed week; four-week move 6.6%.
Indicator stack
6/42
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 57.14%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
52/100
10 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.3% below the Trend Line and sits at 28.6% of its 52-week range. The latest completed week returned 8.3%, after a 6.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1712-week average 0.20
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.17Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.6% over four weeks, -6.7% over 12 weeks, and -15.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year6
Trend breadth11.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.61Latest activity-pressure read.
Pressure change38.1%Four-week change in activity pressure.
Leadership-11.92Latest relative-leadership reading.
RS change41.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 10 relevant articles.
1 positive · 9 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-24.3%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher15 of 2611 weeks finished lower.
Best week+8.3%Week of 31 Jul.
Worst week-10.0%Week of 20 Feb.
Latest week+8.3%Week of 31 Jul.
Shape of recent returns
Strong gains5
Modest gains10
Flat weeks0
Modest losses2
Sharp losses9
Recent vol4.5%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank5 / 40
Group average-1.1%
Trend breadth47.5%
Trend47.5%active weekly trend signals
MD62.5%positive activity pressure
RS42.5%positive relative leadership
Four-week leaders
IndustryCH Drug Manufacturers - Specialty & Generic
4-week rank1 / 5
Group average-5.2%
Trend breadth80.0%
Trend80.0%active weekly trend signals
MD40.0%positive activity pressure
RS80.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape36/100
Trend, activity pressure, participation, and risk combine to a 36/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 3/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.17; No reversal markers Next-Week ExpectancyPositive 57.14%Next-week expectancy is positive with a 57.14% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment52/100Weighted news tone is neutral across 10 relevant articles.
Siegfried Holding (SWX:SFZN) Could Be 27% Undervalued As It Names A New COO Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 76.55 CHF | 8.3% | 79.16 CHF | 87.83 CHF | -0.61 | -11.92 | 428.0K | Off |
| 24 Jul 2026 | 70.70 CHF | -4.1% | 79.09 CHF | 87.82 CHF | -0.77 | -19.15 | 358.2K | Off |
| 17 Jul 2026 | 73.75 CHF | 1.7% | 79.19 CHF | 87.85 CHF | -0.82 | -16.55 | 281.2K | Off |
| 10 Jul 2026 | 72.50 CHF | 1.0% | 79.19 CHF | 87.85 CHF | -0.96 | -17.92 | 449.0K | Off |
| 3 Jul 2026 | 71.80 CHF | 2.6% | 79.20 CHF | 87.87 CHF | -0.98 | -20.37 | 535.8K | Off |
| 26 Jun 2026 | 70.00 CHF | 3.0% | 79.19 CHF | 87.87 CHF | -0.99 | -21.61 | 66.8K | Off |
| 19 Jun 2026 | 67.95 CHF | -7.6% | 79.24 CHF | 87.89 CHF | -0.66 | -22.29 | 266.3K | Off |
| 12 Jun 2026 | 73.50 CHF | -6.2% | 79.35 CHF | 87.92 CHF | -0.42 | -16.30 | 137.2K | Off |
| 5 Jun 2026 | 78.35 CHF | -4.2% | 79.38 CHF | 87.93 CHF | -0.40 | -9.28 | 61.3K | On |
| 29 May 2026 | 81.80 CHF | 1.9% | 79.24 CHF | 87.89 CHF | -0.37 | -6.91 | 340.4K | On |
| 22 May 2026 | 80.25 CHF | 1.7% | 79.08 CHF | 87.84 CHF | -0.55 | -8.90 | 346.2K | On |
| 15 May 2026 | 78.90 CHF | -3.8% | 79.10 CHF | 87.79 CHF | -0.60 | -9.01 | 263.5K | Off |
| 8 May 2026 | 82.05 CHF | 4.3% | 79.08 CHF | 87.76 CHF | -0.49 | -5.02 | 399.1K | Off |
| 1 May 2026 | 78.70 CHF | 1.3% | 78.98 CHF | 87.70 CHF | -0.53 | -9.61 | 293.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.